Ken Griffin
CANO

Ken Griffin’s Cano Health, Inc. CANO Stock Holding History

Ken Griffin’s Portfolio CANO Stock Details CANO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,682
Closed -$93.4K – 15685
2023
Q3 		$93.4K Buy
+3,682
New +$303K ﹤0.01% 10986
2023
Q2 		– Sell
-436
Closed -$55.9K – 15571
2023
Q1 		$39.7K Buy
436
+434
+21,700% +$58.9K ﹤0.01% 12442
2022
Q4 		$314 Sell
2
-100
-98% -$33.9K ﹤0.01% 14697
2022
Q3 		$89K Sell
102
-63,312
-100% -$39.7M ﹤0.01% 11187
2022
Q2 		$27.8M Buy
63,414
+12,982
+26% +$6.77M 0.01% 1526
2022
Q1 		$32M Buy
50,432
+4,181
+9% +$2.64M 0.01% 1478
2021
Q4 		$41.2M Buy
46,251
+3,977
+9% +$4.18M 0.01% 1320
2021
Q3 		$53.6M Sell
42,274
-16,707
-28% -$20.2M 0.01% 1072
2021
Q2 		$71.3M Buy
58,981
+7,826
+15% +$10.6M 0.02% 877
2021
Q1 		$67.8M Buy
51,155
+21,201
+71% +$30M 0.02% 804
2020
Q4 		$40.2M Buy
+29,954
New +$34.3M 0.01% 1132

Other funds holding CANO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Ken Griffin's CANO Position: Q4 2023 in Review

Ken Griffin sold out of Cano Health, Inc. (CANO) in Q4 2023, closing a stake of 3,682 shares — an estimated $93.4K sold.

Ken Griffin first reported a position in CANO in Q4 2020 and held it in 11 quarters. The position peaked at $71.3M in Q2 2021. 50 funds tracked by Wall St. Rank hold CANO as of Q4 2023.

  • Ken Griffin reported no remaining Cano Health, Inc. position as of Q4 2023 after selling out during the quarter.
  • Ken Griffin sold 3,682 Cano Health, Inc. shares in Q4 2023, an estimated $93.4K.
  • Ken Griffin first reported a position in Cano Health, Inc. in Q4 2020 and held it in 11 quarters.
  • Ken Griffin's Cano Health, Inc. position peaked at $71.3M in Q2 2021.
  • 50 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q4 2023.

Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.